Experimental Hematology
Volume 36, Issue 11 , Pages 1496-1506 , November 2008

Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells

  • Slavica Vuckovic

      Affiliations

    • Mater Medical Research Institute, Dendritic Cell Program, South Brisbane, Queensland, Australia
    • Corresponding Author InformationOffprint requests to: Slavica Vuckovic, Ph.D., Mater Medical Research Institute, Dendritic Cell Program, Aubigny Place, Raymond Tce, South Brisbane, QLD 4101, Australia
    • ,
  • Fadilah S. Abdul Wahid

      Affiliations

    • Cell Therapy Center, Hospital University Kebangsaan Malaysia, Kuala Lumpur, Malaysia
    • ,
  • Alison Rice

      Affiliations

    • Mater Medical Research Institute, Dendritic Cell Program, South Brisbane, Queensland, Australia
    • ,
  • Masato Kato

      Affiliations

    • Mater Medical Research Institute, Dendritic Cell Program, South Brisbane, Queensland, Australia
    • ,
  • Dalia Khalil

      Affiliations

    • Mater Medical Research Institute, Dendritic Cell Program, South Brisbane, Queensland, Australia
    • ,
  • Robyn Rodwell

      Affiliations

    • Queensland Cord Blood Bank, Mater Health Services, South Brisbane, Queensland, Australia
    • ,
  • Derek N.J. Hart

      Affiliations

    • Mater Medical Research Institute, Dendritic Cell Program, South Brisbane, Queensland, Australia

Received 14 January 2008 ,Revised 27 May 2008 ,Accepted 18 June 2008.

References 

  1. Koni PA, Joshi SK, Temann UA, Olson D, Burkly L, Flavell RA. Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow. J Exp Med. 2001;193:741–754
  2. Reis e Sousa C, Yap G, Schulz O, et al. Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology. Immunity. 1999;11:637–647
  3. Reis e Sousa C, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 1997;186:1819–1829
  4. Khazaie K, Prifti S, Beckhove P, et al. Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection. Proc Natl Acad Sci U S A. 1994;91:7430–7434
  5. Feuerer M, Beckhove P, Garbi N, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med. 2003;9:1151–1157
  6. Hommel M, Kyewski B. Dynamic changes during the immune response in T cell-antigen-presenting cell clusters isolated from lymph nodes. J Exp Med. 2003;197:269–280
  7. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285:412–415
  8. Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8:575–581
  9. Zhang Y, Shlomchik WD, Joe G, et al. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol. 2002;169:7111–7118
  10. Palucka AK, Gatlin J, Blanck JP, et al. Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors. Blood. 2003;102:3302–3310
  11. Cravens PD, Melkus MW, Padgett-Thomas A, Islas-Ohlmayer M, Del PMM, Garcia JV. Development and activation of human dendritic cells in vivo in a xenograft model of human hematopoiesis. Stem Cells. 2005;23:264–278
  12. Melkus MW, Estes JD, Padgett-Thomas A, et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med. 2006;12:1316–1322
  13. Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood. 2005;106:1565–1573
  14. Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004;304:104–107
  15. Rice AM, Wood JA, Milross CG, Collins CJ, McCarthy NF, Vowels MR. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice. Transplantation. 2000;69:927–935
  16. Hogan CJ, Shpall EJ, McNulty O, et al. Engraftment and development of human CD34(+)-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood. 1997;90:85–96
  17. Kato M, McDonald KJ, Khan S, et al. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int Immunol. 2006;18:857–869
  18. Hock BD, Starling GC, Daniel PB, Hart DN. Characterization of CMRF-44, a novel monoclonal antibody to an activation antigen expressed by the allostimulatory cells within peripheral blood, including dendritic cells. Immunology. 1994;83:573–581
  19. Hock BD, Fearnley DB, Boyce A, et al. Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens. 1999;53:320–334
  20. McKinlay A, Radford K, Kato M, et al. Blood monocytes, myeloid dendritic cells and the cytokines interleukin (IL)-7 and IL-15 maintain human CD4+ T memory cells with mixed helper/regulatory function. Immunology. 2007;120:392–403
  21. Osugi Y, Vuckovic S, Hart DN. Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes. Blood. 2002;100:2858–2866
  22. Vuckovic S, Gardiner D, Field K, et al. Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. J Immunol Methods. 2004;284:73–87
  23. McIlroy D, Troadec C, Grassi F, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470–3477
  24. Muller M, Gounari F, Prifti S, Hacker HJ, Schirrmacher V, Khazaie K. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res. 1998;58:5439–5446
  25. Li R, Perez N, Karumuthil-Melethil S, Vasu C. Bone marrow is a preferential homing site for autoreactive T-cells in type 1 diabetes. Diabetes. 2007;56:2251–2259
  26. Zhang Y, Louboutin JP, Zhu J, Rivera AJ, Emerson SG. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest. 2002;109:1335–1344
  27. Egner W, Hart DN. The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations. Immunology. 1995;85:611–620
  28. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood. 2002;100:4512–4520
  29. Abbasian J, Mahmud D, Mahmud N, et al. Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function. Blood. 2006;108:203–208
  30. Sanarico N, Ciaramella A, Sacchi A, et al. Human monocyte-derived dendritic cells differentiated in the presence of IL-2 produce proinflammatory cytokines and prime Th1 immune response. J Leukoc Biol. 2006;80:555–562
  31. Delneste Y, Charbonnier P, Herbault N, et al. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood. 2003;101:143–150
  32. Vuckovic S, Clark GJ, Hart DN. Growth factors, cytokines and dendritic cell development. Curr Pharm Des. 2002;8:405–418
  33. Anderson BE, Taylor PA, McNiff JM, et al. Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells. Blood. 2008;111:5242–5251

PII: S0301-472X(08)00308-1

doi: 10.1016/j.exphem.2008.06.011

Experimental Hematology
Volume 36, Issue 11 , Pages 1496-1506 , November 2008

Article Tools

* Image Usage & Resolution